Baotai Liang

Baotai Biopharmaceutical is a Chinese biotechnology company focused on the research, development, and commercialization of innovative therapies for chronic viral infections and liver diseases. The company's primary focus is the development of functional cures for Chronic Hepatitis B (CHB) through a combination of novel small molecules and immunotherapies. Baotai leverages its proprietary drug discovery platforms to target various stages of the viral life cycle and host immune response. Headquartered in Beijing, the company maintains a robust pipeline of candidates ranging from preclinical to mid-stage clinical trials, aiming to address significant unmet medical needs in the hepatology space.